Tech Company Financing Transactions
Healome Therapeutics Funding Round
On 7/7/2026, Healome Therapeutics announced $2.7 million in Seed funding from Empirical Ventures and SFC Capital.
Transaction Overview
Company Name
Announced On
7/7/2026
Transaction Type
Venture Equity
Amount
$2,700,000
Round
Seed
Investors
Empirical Ventures (Lead Investor)
Proceeds Purpose
The company intends to use the funds for pre-clinical development, manufacturing scale-up, regulatory engagement with the MHRA and FDA, and progression toward first-in-human studies expected in 2027.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Birmingham Research Park, 97 Vincent Drive
Birmingham, B15 2SQ
UK
Birmingham, B15 2SQ
UK
Phone
Undisclosed
Website
Email Address
Overview
Healome Therapeutics is an ophthalmology and ocular drug delivery company aiming to improve the safety, effectiveness, and usability of ocular drugs and treatment of ocular surface conditions. Vision: Better medicine by developing treatment approaches that better address the drivers and quality of life impacts of ocular diseases and injuries. Better healthcare by deploying 'better medicine' at scale in a way that enables healthcare providers and people to effectively manage the growing and evolving eye health challenges around the world.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Richard Williams
Co-Founder
Liam Grover
Co-Founder
Tony Metcalfe
Co-Founder
Richard Moakes
Browse more venture capital transactions:
Prev: 7/7/2026: Forge Industries venture capital transaction
Next: 7/7/2026: Adaptive Insurance venture capital transaction
Share this article
News on VC Transactions
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs